Volume 21, Issue 5, Pages (May 2015)

Slides:



Advertisements
Similar presentations
Human Brown Adipose Tissue Sven Enerbäck Cell Metabolism Volume 11, Issue 4, Pages (April 2010) DOI: /j.cmet Copyright © 2010.
Advertisements

Volume 5, Issue 10, Pages (October 2016)
Peter L. Lee, Yuefeng Tang, Huawei Li, David A. Guertin 
Volume 10, Issue 4, Pages (October 2009)
Elsie Gonzalez-Hurtado, Jieun Lee, Joseph Choi, Michael J. Wolfgang
Volume 9, Issue 5, Pages (December 2014)
Volume 26, Issue 4, Pages e4 (October 2017)
Volume 11, Issue 1, Pages (January 2010)
Beneficial Effects of Subcutaneous Fat Transplantation on Metabolism
Volume 11, Issue 3, Pages (March 2010)
Volume 35, Issue 5, Pages (December 2015)
Volume 24, Issue 6, Pages (December 2016)
Volume 24, Issue 3, Pages (September 2016)
Volume 26, Issue 4, Pages e3 (October 2017)
Volume 11, Issue 2, Pages (February 2010)
Volume 13, Issue 8, Pages (November 2015)
Beneficial Effects of Subcutaneous Fat Transplantation on Metabolism
Volume 6, Issue 3, Pages (September 2007)
Volume 18, Issue 2, Pages (August 2013)
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Volume 26, Issue 5, Pages e3 (November 2017)
Volume 17, Issue 5, Pages (May 2013)
Volume 25, Issue 2, Pages (February 2017)
Volume 3, Issue 3, Pages (March 2006)
Volume 19, Issue 1, Pages (January 2014)
Protection against High-Fat-Diet-Induced Obesity in MDM2C305F Mice Due to Reduced p53 Activity and Enhanced Energy Expenditure  Shijie Liu, Tae-Hyung.
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Heat Shock Transcription Factor 1 Is a Key Determinant of HCC Development by Regulating Hepatic Steatosis and Metabolic Syndrome  Xiongjie Jin, Demetrius.
Volume 22, Issue 4, Pages (October 2015)
Volume 13, Issue 8, Pages (November 2015)
Volume 9, Issue 2, Pages (February 2009)
Volume 9, Issue 5, Pages (May 2009)
Volume 16, Issue 4, Pages (October 2012)
Volume 3, Issue 2, Pages (February 2006)
Volume 20, Issue 1, Pages (July 2014)
Volume 14, Issue 7, Pages (February 2016)
Volume 10, Issue 5, Pages (November 2009)
Volume 11, Issue 3, Pages (March 2010)
Volume 25, Issue 4, Pages e4 (April 2017)
Volume 9, Issue 1, Pages (January 2009)
Volume 5, Issue 5, Pages (May 2007)
Syntaxin 4 Overexpression Ameliorates Effects of Aging and High-Fat Diet on Glucose Control and Extends Lifespan  Eunjin Oh, Richard A. Miller, Debbie C.
Volume 15, Issue 5, Pages (May 2012)
Volume 6, Issue 3, Pages (September 2007)
Volume 6, Issue 5, Pages (November 2007)
Volume 14, Issue 4, Pages (October 2011)
Roles for leptin receptor/STAT3-dependent and -independent signals in the regulation of glucose homeostasis  Sarah H. Bates, Rohit N. Kulkarni, Matthew.
Volume 16, Issue 3, Pages (July 2016)
Volume 25, Issue 5, Pages (October 2018)
Volume 8, Issue 5, Pages (November 2008)
Volume 14, Issue 6, Pages (February 2016)
Volume 13, Issue 4, Pages (April 2011)
Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice  Decheng Ren, Minghua Li, Chaojun Duan, Liangyou.
EBF2 Determines and Maintains Brown Adipocyte Identity
Mitofusin 2 in Mature Adipocytes Controls Adiposity and Body Weight
PPARγ in Vagal Neurons Regulates High-Fat Diet Induced Thermogenesis
Volume 20, Issue 4, Pages (October 2014)
Cbx4 Sumoylates Prdm16 to Regulate Adipose Tissue Thermogenesis
Lipin, a lipodystrophy and obesity gene
Volume 26, Issue 5, Pages e3 (November 2017)
Volume 4, Issue 5, Pages (November 2006)
Joan Goulley, Ulf Dahl, Nathalie Baeza, Yuji Mishina, Helena Edlund 
Clémence Blouet, Hiraku Ono, Gary J. Schwartz  Cell Metabolism 
Adipose Fatty Acid Oxidation Is Required for Thermogenesis and Potentiates Oxidative Stress-Induced Inflammation  Jieun Lee, Jessica M. Ellis, Michael J.
Volume 24, Issue 6, Pages (December 2016)
Brown Adipose Tissue Thermogenic Capacity Is Regulated by Elovl6
Volume 26, Issue 1, Pages 1-10.e7 (January 2019)
Volume 16, Issue 3, Pages (September 2012)
Volume 6, Issue 6, Pages (December 2007)
Volume 4, Issue 4, Pages (October 2006)
Presentation transcript:

Volume 21, Issue 5, Pages 731-738 (May 2015) Pharmacologic Effects of FGF21 Are Independent of the “Browning” of White Adipose Tissue  Murielle M. Véniant, Glenn Sivits, Joan Helmering, Renee Komorowski, Jae Lee, Wei Fan, Carolyn Moyer, David J. Lloyd  Cell Metabolism  Volume 21, Issue 5, Pages 731-738 (May 2015) DOI: 10.1016/j.cmet.2015.04.019 Copyright © 2015 Elsevier Inc. Terms and Conditions

Cell Metabolism 2015 21, 731-738DOI: (10.1016/j.cmet.2015.04.019) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 1 FGF21-Fc Is Efficacious in Lean and DIO Mice Housed in Standard or Thermoneutral Environments (A–D) Chow-fed, lean mice housed at 21°C or 30°C were treated with vehicle or 3 mg/kg human FGF21-Fc per Animal Study Design I. Body weight was monitored over 15 days, plasma glucose and insulin levels were measured on days 0 and 12, and glucose tolerance was assessed on day 15. (E–H) DIO mice housed at 21°C or 30°C were treated with 0.5 or 3 mg/kg human FGF21-Fc. Body weight was monitored over 15 days, plasma glucose and insulin levels were measured on days 0 and 11, and glucose tolerance was assessed on day 15. (I) BAT morphology (H&E) of lean mice from (A)–(D). Bars represent 200 μm. (J) BAT morphology (H&E) of DIO mice from (E)–(H). Bars represent 200 μm. (K) iWAT morphology (H&E) of lean mice from (A)–(D). Bars represent 200 μm. Inset (red box) shows higher magnification of multilocular adipocytes. Bars represent 100 μm. (L) iWAT morphology (H&E) of DIO mice from (E)–(H). Bars represent 200 μm. (M and N) BAT and iWAT were excised from lean and DIO mice after completion of Animal Study Design I, and two lysates from each group were analyzed by immunoblot for UCP1. A BAT lysate from a wild-type C57BL/6 mouse was used as a positive control to highlight a nonspecific immunoreactive band in iWAT (arrow). α/β-tubulin was used as a loading control. Data represent mean ± SEM (n = 8/group), analyzed by ANCOVA. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 versus vehicle control. See also Figures S1 and S2 and Tables S1 and S2. Cell Metabolism 2015 21, 731-738DOI: (10.1016/j.cmet.2015.04.019) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 2 FGF21-Fc Is Efficacious in Ucp1−/− Mice (A–G) Ucp1+/− and Ucp1−/− mice housed at 30°C were treated with vehicle or 3 mg/kg human FGF21-Fc as described in Animal Study Design II. Body weight was monitored over 15 days; plasma glucose, insulin, cholesterol, triglycerides, and NEFA were measured on days 0 and 11; and glucose tolerance was assessed on day 15. Data represent mean ± SEM (n = 4–6 mice/group), analyzed by ANCOVA. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 versus vehicle control. (H) Immunoblot analysis of BAT and iWAT lysates (two from each group) from Ucp1+/− and Ucp1−/− mice treated with human FGF21-Fc. A BAT lysate from a wild-type C57BL/6 mouse was used as a positive control to highlight a nonspecific band (arrow). α/β-tubulin was used as a loading control. See also Table S3. Cell Metabolism 2015 21, 731-738DOI: (10.1016/j.cmet.2015.04.019) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 3 Increased Energy Expenditure in FGF21-Fc-Treated Ucp1−/− Mice (A–F) Ucp1+/− and Ucp1−/− mice housed at 30°C were treated with vehicle or 3 mg/kg human FGF21-Fc per Animal Study Design II while housed in indirect calorimetry chambers. Body weight and food intake were monitored over 15 days; O2 consumption (VO2), CO2 production (VCO2), respiratory exchange ratio, and physical activity were monitored on day and night 5. Data represent mean ± SEM (n = 4 mice/group) of actual data (A and B) or whole day and night averages (C–F), analyzed by ANCOVA. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 versus vehicle control of same genotype; ns, nonsignificant. Cell Metabolism 2015 21, 731-738DOI: (10.1016/j.cmet.2015.04.019) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 4 Gene Expression in iWAT and BAT of FGF21-Fc-Treated Ucp1−/− Mice Fold change is expressed relative to vehicle-treated Ucp1+/− mice, except for iWAT Ucp1 expression, which was only detected in Ucp1+/− FGF21-Fc-treated mice. Data are expressed in RT-PCR threshold cycles (Ct). An outlier based on Ucp1 expression was identified, marked with an empty circle, and excluded from statistical analyses. Data represent individual values (n = 7–8/group), analyzed by one-way ANOVA. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 in pairwise comparisons as indicated; only significant changes are displayed. See also Table S4. Cell Metabolism 2015 21, 731-738DOI: (10.1016/j.cmet.2015.04.019) Copyright © 2015 Elsevier Inc. Terms and Conditions